Fluticasone Diskus 250 Micrograms (Fluticasone Propionate (Micronized))

Adult use

This medication should only be administered via inhalation. Adults and youths over 16 years should take 100-1000 μg by inhalation twice daily. Adjust dosing according to the severity of the condition, with mild cases typically receiving 100-250 μg twice daily, moderate cases 250-500 μg twice daily, and severe cases 500-1000 μg twice daily. After administration, adjust the dosage according to individual response until asthma is controlled or the minimum effective dose is reached.

Child use

Children aged 4-16 years should take 50-100 μg by inhalation twice daily. Initiate dosing with 50-100 μg twice daily depending on the severity of asthma, and adjust the dose according to individual response.

This medication should not be used in patients with severe milk protein allergies or with a history of hypersensitivity to any of its components. It is not suitable for treating severe asthma conditions or as the first-line treatment during acute asthma attacks, and other treatments should be used. Patients with moderate to severe bronchiectasis should use this medication with caution. Patients with pulmonary tuberculosis or pulmonary fungal infections should be cautious when using this medication and should consult their doctor if they are undergoing treatment. Rarely, bronchospasm may occur while using this medication, so if symptoms appear, immediate consultation with healthcare professionals is required. Candidiasis, a fungal infection, may occur in the mouth and throat, so it is advisable to rinse the mouth thoroughly after inhalation. Long-term use at high doses may lead to systemic side effects such as adrenal insufficiency, growth retardation, cataracts, and glaucoma, so regular check-ups by a physician are necessary. This medication is not intended for treating acute asthma attacks; in case of sudden symptom worsening, a fast-acting bronchodilator should be used. During pregnancy, the risks and benefits should be evaluated by a physician; and during lactation, the effects on the newborn should also be taken into consideration. There may be drug interactions, especially when taken with certain medications such as Ritonavir, so it is essential to consult a doctor or pharmacist. In children, growth should be monitored regularly, and it is advisable to avoid use in children under the age of 4. Do not abruptly discontinue this medication; dosage should be gradually adjusted according to the doctor's instructions, and vigilance for adrenal insufficiency or asthma exacerbation should be maintained. Ensure proper usage of the inhaler, and rinse the mouth with water after use to prevent infections and side effects. Store in a cool, dry place out of reach of children and close the inhaler when not in use.

Serious side effects

Hives, angioedema (primarily facial and oral cavity swelling), difficulty breathing, bronchospasm, anaphylactic reactions, paradoxical bronchospasm, swelling of the face and oral cavity, throat symptoms (discomfort, difficulty breathing), dyspnea, pneumonia, severe swelling

Mild side effects

Candidiasis in the mouth and throat, pneumonia, esophageal candidiasis, skin hypersensitivity reactions, Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataracts, glaucoma, hyperglycemia, anxiety, sleep disturbances, hyperactivity and irritability, hoarseness, paradoxical bronchospasm, bruising, swelling of the face and oral cavity, throat symptoms, sputum, dry mouth, infections, speech disorders, nasal discharge, allergic rhinitis, sinusitis,

This medication should be stored at room temperature, away from extremes of heat and cold, to maintain its effectiveness.

Appearance

A powder that is white or off-white, contained in a round orange plastic device approximately 8.5 cm in diameter and 3 cm in height, which is equipped with a counter indicating the remaining dosage.

Package unit

60 sprays/container